Gianvincenzo Sparacia1,2, Roberto Cannella3, Vincenzina Lo Re4, Angelo Gambino3, Giuseppe Mamone5, Roberto Miraglia5. 1. Department of Radiology, University of Palermo, Palermo, Italy. gsparacia@ismett.edu. 2. Department of Diagnostic and Therapeutic Services, IRCCS-ISMETT (Mediterranean Institute for Transplantation and Advanced Specialized Therapies), Palermo, Italy. gsparacia@ismett.edu. 3. Department of Radiology, University of Palermo, Palermo, Italy. 4. Neurology Unit, IRCCS-ISMETT (Mediterranean Institute for Transplantation and Advanced Specialized Therapies), Palermo, Italy. 5. Department of Diagnostic and Therapeutic Services, IRCCS-ISMETT (Mediterranean Institute for Transplantation and Advanced Specialized Therapies), Palermo, Italy.
Abstract
PURPOSE: Cerebral microbleeds (CMBs) are small rounded lesions representing cerebral hemosiderin deposits surrounded by macrophages that results from previous microhemorrhages. The aim of this study was to review the distribution of cerebral microbleeds in patients with end-stage organ failure and their association with specific end-stage organ failure risk factors. MATERIALS AND METHODS: Between August 2015 and June 2017, we evaluated 15 patients, 9 males, and 6 females, (mean age 65.5 years). Patients population was subdivided into three groups according to the organ failure: (a) chronic kidney failure (n = 8), (b) restrictive cardiomyopathy undergoing heart transplantation (n = 1), and (c) end-stage liver failure undergoing liver transplantation (n = 6). The MR exams were performed on a 3T MR unit and the SWI sequence was used for the detection of CMBs. CMBs were subdivided in supratentorial lobar distributed, supratentorial non-lobar distributed, and infratentorial distributed. RESULTS: A total of 91 microbleeds were observed in 15 patients. Fifty-nine CMBs lesions (64.8%) had supratentorial lobar distribution, 17 CMBs lesions (18.8%) had supratentorial non-lobar distribution and the remaining 15 CMBs lesions (16.4%) were infratentorial distributed. An overall predominance of supratentorial multiple lobar localizations was found in all types of end-stage organ failure. The presence of CMBs was significantly correlated with age, hypertension, and specific end-stage organ failure risk factors (p < 0.001). CONCLUSIONS: CMBs are mostly founded in supratentorial lobar localization in end-stage organ failure. The improved detection of CMBs with SWI sequences may contribute to a more accurate identification of patients with cerebral risk factors to prevent complications during or after the organ transplantation.
PURPOSE: Cerebral microbleeds (CMBs) are small rounded lesions representing cerebral hemosiderin deposits surrounded by macrophages that results from previous microhemorrhages. The aim of this study was to review the distribution of cerebral microbleeds in patients with end-stage organ failure and their association with specific end-stage organ failure risk factors. MATERIALS AND METHODS: Between August 2015 and June 2017, we evaluated 15 patients, 9 males, and 6 females, (mean age 65.5 years). Patients population was subdivided into three groups according to the organ failure: (a) chronic kidney failure (n = 8), (b) restrictive cardiomyopathy undergoing heart transplantation (n = 1), and (c) end-stage liver failure undergoing liver transplantation (n = 6). The MR exams were performed on a 3T MR unit and the SWI sequence was used for the detection of CMBs. CMBs were subdivided in supratentorial lobar distributed, supratentorial non-lobar distributed, and infratentorial distributed. RESULTS: A total of 91 microbleeds were observed in 15 patients. Fifty-nine CMBs lesions (64.8%) had supratentorial lobar distribution, 17 CMBs lesions (18.8%) had supratentorial non-lobar distribution and the remaining 15 CMBs lesions (16.4%) were infratentorial distributed. An overall predominance of supratentorial multiple lobar localizations was found in all types of end-stage organ failure. The presence of CMBs was significantly correlated with age, hypertension, and specific end-stage organ failure risk factors (p < 0.001). CONCLUSIONS:CMBs are mostly founded in supratentorial lobar localization in end-stage organ failure. The improved detection of CMBs with SWI sequences may contribute to a more accurate identification of patients with cerebral risk factors to prevent complications during or after the organ transplantation.
Entities:
Keywords:
Cerebral microbleeds; End-stage organ failure; Magnetic resonance imaging; Susceptibility-weighted imaging; Transplantation
Authors: Charlotte Cordonnier; Gillian M Potter; Caroline A Jackson; Fergus Doubal; Sarah Keir; Cathie L M Sudlow; Joanna M Wardlaw; Rustam Al-Shahi Salman Journal: Stroke Date: 2008-11-13 Impact factor: 7.914
Authors: Sara Shams; Tobias Granberg; Juha Martola; Andreas Charidimou; Xiaozhen Li; Mana Shams; Seyed-Mohammad Fereshtehnejad; Lena Cavallin; Peter Aspelin; Maria Wiberg-Kristoffersen; Lars-Olof Wahlund Journal: J Cereb Blood Flow Metab Date: 2016-07-21 Impact factor: 6.200
Authors: Bruce Ovbiagele; Jeffrey J Wing; Ravi S Menon; Richard E Burgess; M Christopher Gibbons; Ian Sobotka; Laura German; Nawar M Shara; Stephen Fernandez; Annapurni Jayam-Trouth; Dorothy Farrar Edwards; Chelsea S Kidwell Journal: Stroke Date: 2013-07-11 Impact factor: 7.914
Authors: Andreas Charidimou; Duncan Wilson; Clare Shakeshaft; Gareth Ambler; Mark White; Hannah Cohen; Tarek Yousry; Rustam Al-Shahi Salman; Gregory Lip; Henry Houlden; Hans R Jäger; Martin M Brown; David J Werring Journal: Int J Stroke Date: 2015-08-02 Impact factor: 5.266